Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide-Reference-Cited by-同舟云学术

Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide

Published:1989-06 Issue:6 Volume:6 Page:455-458
ISSN:0882-4010
Container-title:Microbial Pathogenesis
language:en
Short-container-title:Microbial Pathogenesis

Author:

Ashton F.E.,Ryan J.A.,Michon F.,Jennings H.J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference14 articles.

1. Immunologic response of man to group B meningococcal polysaccharide vaccines;Wyle;J Infect Dis,1972

2. Meningococcal disease: still with us;Peltola;Rev Inf Dis,1983

3. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine;Jennings;J Immunol,1986

4. N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis;Jennings;J Exp Med,1987

5. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1;Jennings;J Immunol,1989

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-cell depolymerization of polysaccharide antigens. Exploring the processing pathways of glycans and why some glycoconjugate vaccines are less effective than expected: A review;Carbohydrate Polymers;2023-09

2. Meningococcal Vaccines: Current Status and Emerging Strategies;Vaccines;2018-02-25

3. Novel approaches to Neisseria meningitidis vaccine design;Pathogens and Disease;2017-03-22

4. From empiricism to rational design: a personal perspective of the evolution of vaccine development;Nature Reviews Immunology;2014-06-13

5. Synthesis and Immunological Characterization of Modified Hyaluronic Acid Hexasaccharide Conjugates;The Journal of Organic Chemistry;2013-07-26